Analyst Ratings for Phathom Pharmaceuticals (PHAT) [Buys]

PHAT Rating Summary

PHAT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PHAT
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $56.67 (+69.5%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/14/2021 Jones Trading Prakhar Agrawal New Coverage Buy
(N/A)
50.00
(N/A)
35.08
(33.43)
-4.7% Details
2/17/2021 BMO Capital Gary Nachman New Coverage Outperform
(N/A)
63.00
(N/A)
44.58
(33.43)
-25.01% Details
Like PHAT Ratings? Also take a look at TEVA, AMRX, RCKT, TRIL

PHAT Ratings News